🇺🇸 Lasix 25 in United States
39 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 39
Most-reported reactions
- Drug Interaction — 8 reports (20.51%)
- Renal Failure Acute — 5 reports (12.82%)
- Asthenia — 4 reports (10.26%)
- Hyperkalaemia — 4 reports (10.26%)
- Hypotension — 4 reports (10.26%)
- Anaemia — 3 reports (7.69%)
- Malaise — 3 reports (7.69%)
- Thrombocytopenia — 3 reports (7.69%)
- Vomiting — 3 reports (7.69%)
- Abdominal Pain Upper — 2 reports (5.13%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Lasix 25 approved in United States?
Lasix 25 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Lasix 25 in United States?
Heart Care Foundation is the originator. The local marketing authorisation holder may differ — check the official source linked above.